![Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) | The BMJ Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) | The BMJ](https://www.bmj.com/sites/default/files/sites/defautl/files/attachments/bmj-article/2016/01/betahistine.jpg)
Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) | The BMJ
![БЕТАГИСТИН ТЕВА ( бетагистина дигидрохлорид) (BETAHISTINE TEVA (betahistine dihydrochloride)) | Поиск, заказ, доставка лекарств в Казахстане. +7(727) 350-59-11 БЕТАГИСТИН ТЕВА ( бетагистина дигидрохлорид) (BETAHISTINE TEVA (betahistine dihydrochloride)) | Поиск, заказ, доставка лекарств в Казахстане. +7(727) 350-59-11](https://likitoria.kz/dbs5.files/i/product/75171.jpg)
БЕТАГИСТИН ТЕВА ( бетагистина дигидрохлорид) (BETAHISTINE TEVA (betahistine dihydrochloride)) | Поиск, заказ, доставка лекарств в Казахстане. +7(727) 350-59-11
![Amoksiklav 2x1000 mg film-coated tablets; Dose: 875 mg/125 mg; Package: ;Diagnosis: J11.0, J11.1, J11.8 Amoksiklav 2x1000 mg film-coated tablets; Dose: 875 mg/125 mg; Package: ;Diagnosis: J11.0, J11.1, J11.8](https://dati.zva.gov.lv/zalu-registrs/attachments/label/2440056/I001223-0101771089.jpg)
Amoksiklav 2x1000 mg film-coated tablets; Dose: 875 mg/125 mg; Package: ;Diagnosis: J11.0, J11.1, J11.8
![Formularium herverpakte producten cnk omschrijving .2742864 Aceclofenac Teva 100mg 60 1597871 Actonel - [PDF Document] Formularium herverpakte producten cnk omschrijving .2742864 Aceclofenac Teva 100mg 60 1597871 Actonel - [PDF Document]](https://demo.vdocuments.net/img/378x509/reader019/reader/2020041609/5ba11de809d3f2bb6a8bb4e3/r-1.jpg)